{"id":4394,"date":"2025-03-31T18:12:06","date_gmt":"2025-03-31T18:12:06","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/teicoplanin-txt\/"},"modified":"2025-03-31T18:12:06","modified_gmt":"2025-03-31T18:12:06","slug":"teicoplanin-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/teicoplanin-txt\/","title":{"rendered":"Teicoplanin.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3><br \/>\nAntibacterial agent<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>Loading dose: 400 mg every 12 hours for 3 doses, thenIM\/IV: 200\u2013400 mg daily, or 3\u20136 mg\/kg\/day (up to 10 mg\/kg\/day in some reports) in life threatening infections<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :1875\u20131891<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :90\u201395<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : &gt;97<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.94\u20131.4<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :150\/62\u2013230<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : Give normal loading dose, then dose as in normal renal function<LI> 10 to 20  &amp;nbsp &amp;nbsp : Give normal loading dose, then 200\u2013400 mg every 24\u201348 hours<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Give normal loading dose, then 200\u2013400 mg every 48\u201372 hours<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Not dialysed. Dose as in GFR &lt;10 mL\/min<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Not dialysed. Dose as in GFR &lt;10 mL\/min<LI>HDF\/high flux  &amp;nbsp :Dialysed.1 Dose as in  GFR &lt;10 mL\/min<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Unknown dialysability. Dose as in GFR 10 to 20   mL\/min <H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugs\n<li>None known <H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>Use water for injection provided <H4>  Route  <\/H4>IV, IM <H4>  Rate of Administration  <\/H4>IV bolus: 2\u20133 minutes; <H4> IV infusion  <\/H4>:  30 minutes<H4>Comments<\/H4>USE IN <LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp: Give 400 mg IV stat dose, then 20 mg\/L\/ bag IP for 7 days, then 20 mg\/L\/alternate-bag for 7 days, then 20 mg\/L\/night-bag only for 7 days<H4>  OTHER INFORMATION  <\/H4>TDM optimises therapy, but not essential.  Troughs not less than 10 mg\/L. Peaks 1 hour after: <LI> 20 to 50  &amp;nbsp &amp;nbsp : mg\/LRelationship between blood level and  toxicity not establishedLong-term concurrent use of gentamicin  and teicoplanin causes additive ototoxicity<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Antibacterial agent DOSE IN NORMAL RENAL FUNCTION Loading<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4394","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4394"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4394\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}